Pathogenetic therapy of heart failure: beta-adrenoblockers

Author:

Shayduk O. Yu.1,Taratukhin E. O.1

Affiliation:

1. N. I. Pirogov Russian National Medical University, Moscow

Abstract

The paper discusses key aspects of the chronic heart failure (CHF) pathogenesis, which justify the use of β-adrenoblockers (β-AB) in the treatment of CHF. The authors present the clinical and experimental evidence confirming the effectiveness of these agents in CHF patients. Dose titration and the use of β-AB in various clinical groups are also discussed.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Libby P, Bonow L, Zipes D, et al. Braunwald’s Heart Disease. 8th ed / Elsevier. - 2008

2. Floras JS. Alterations in the sympathetic and parasympathetic nervous system in Heart Failure. In Mann DL [ed]: Heart Failure: A companion to Braunwald’s Heart Disease. Elsevier 2004.

3. Katzung B, Masters S, Trevor A. Basic and Clinical Pharmacology. 12th ed. Lange 2011.

4. National Guidelines for Heart Failure. 3rd ed. Heart Failure 2010; 1(11). Russian (Natsional'nye rekomendatsii VNOK i OSSN (tretii peresmotr). Serd nedostat 2010; 1(11).

5. Allen LA, Stevenson LW, Grady KL, et al. AHA Scientific Statement: Decision Making in Advanced Heart Failure. Circulation 2012; 125: 1928-52.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3